These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34611073)

  • 21. Bullous drug eruption after second dose of mRNA-1273 (Moderna) COVID-19 vaccine: Case report.
    Kong J; Cuevas-Castillo F; Nassar M; Lei CM; Idrees Z; Fix WC; Halverstam C; Mir A; Elbendary A; Mathew A
    J Infect Public Health; 2021 Oct; 14(10):1392-1394. PubMed ID: 34294590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AstraZeneca (AZD1222) COVID-19 vaccine-associated adverse drug event: A case report.
    Capassoni M; Ketabchi S; Cassisa A; Caramelli R; Molinu AA; Galluccio F; Guiducci S
    J Med Virol; 2021 Oct; 93(10):5718-5720. PubMed ID: 34214206
    [No Abstract]   [Full Text] [Related]  

  • 23. Guidance for Implementing COVID-19 Prevention Strategies in the Context of Varying Community Transmission Levels and Vaccination Coverage.
    Christie A; Brooks JT; Hicks LA; Sauber-Schatz EK; Yoder JS; Honein MA;
    MMWR Morb Mortal Wkly Rep; 2021 Jul; 70(30):1044-1047. PubMed ID: 34324480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute tolerance of Moderna mRNA-1273 vaccine against COVID-19 in patients with cancer treated with radiotherapy.
    Scoccianti S; Delli Paoli C; Grilli Leonulli B; Paoletti L; Alpi P; Caini S; Barca R; Fondelli S; Russo S; Perna M; Pino MS; Martella F; Furlan F; Bassetti A; Fioretto L
    Lancet Oncol; 2021 Sep; 22(9):1212-1214. PubMed ID: 34388385
    [No Abstract]   [Full Text] [Related]  

  • 25. Effectiveness of inactivated SARS-CoV-2 vaccines against the Delta variant infection in Guangzhou: a test-negative case-control real-world study.
    Li XN; Huang Y; Wang W; Jing QL; Zhang CH; Qin PZ; Guan WJ; Gan L; Li YL; Liu WH; Dong H; Miao YT; Fan SJ; Zhang ZB; Zhang DM; Zhong NS
    Emerg Microbes Infect; 2021 Dec; 10(1):1751-1759. PubMed ID: 34396940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SARS-CoV-2 vaccines in patients with SLE.
    Tang W; Askanase AD; Khalili L; Merrill JT
    Lupus Sci Med; 2021 Mar; 8(1):. PubMed ID: 33685998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Response to McMahon et al's "Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of four hundred fourteen cases".
    Poulas K; Farsalinos K
    J Am Acad Dermatol; 2022 Apr; 86(4):e163-e164. PubMed ID: 34801633
    [No Abstract]   [Full Text] [Related]  

  • 28. COVID-19 Vaccine Reactions in Dermatology: "Filling" in the Gaps.
    Rice SM; Ferree SD; Kourosh AS
    Cutis; 2021 Jun; 107(6):288-290. PubMed ID: 34314309
    [No Abstract]   [Full Text] [Related]  

  • 29. Coronavirus Vaccination Adverse Reactions and the Role of the Dermatologist.
    Pulsipher KJ; Presley CL; Waller JD; Szeto MD; Laughter MR; Dellavalle RP
    J Drugs Dermatol; 2021 Mar; 20(3):351-352. PubMed ID: 33683080
    [No Abstract]   [Full Text] [Related]  

  • 30. Idiopathic Thrombocytopenic Purpura and the Moderna Covid-19 Vaccine.
    Julian JA; Mathern DR; Fernando D
    Ann Emerg Med; 2021 Jun; 77(6):654-656. PubMed ID: 34030782
    [No Abstract]   [Full Text] [Related]  

  • 31. Herpes Zoster Following COVID-19 Vaccination.
    David E; Landriscina A
    J Drugs Dermatol; 2021 Aug; 20(8):898-900. PubMed ID: 34397201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early Safety Monitoring of COVID-19 Vaccines in Healthcare Workers.
    Song JY; Cheong HJ; Kim SR; Lee SE; Kim SH; Noh JY; Yoon YK; Choi WS; Park DW; Sohn JW; Kim WJ; Kim MJ
    J Korean Med Sci; 2021 Apr; 36(15):e110. PubMed ID: 33876589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Side Effects after mRNA COVID-19 Vaccine as a Booster in Health Workers.
    Pakki TR; Mariana N; Tampubolon ML; Rusli A; Romadhona S; Intan AD; Chohan Z; Widiantari AD; Herlina H; Puspitasari A; Mahardika M; Suliati S; Maemun S; Murtiani F; Syahril M
    Iran J Public Health; 2022 Nov; 51(11):2504-2509. PubMed ID: 36561250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myocarditis After BNT162b2 and mRNA-1273 Vaccination.
    Larson KF; Ammirati E; Adler ED; Cooper LT; Hong KN; Saponara G; Couri D; Cereda A; Procopio A; Cavalotti C; Oliva F; Sanna T; Ciconte VA; Onyango G; Holmes DR; Borgeson DD
    Circulation; 2021 Aug; 144(6):506-508. PubMed ID: 34133884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety of an inactivated SARS-CoV-2 vaccine among healthcare workers in China.
    Zhang MX; Zhang TT; Shi GF; Cheng FM; Zheng YM; Tung TH; Chen HX
    Expert Rev Vaccines; 2021 Jul; 20(7):891-898. PubMed ID: 33929930
    [No Abstract]   [Full Text] [Related]  

  • 36. COVID-19 Vaccine for Elderly: Should We Be Reactive or Proactive?
    Setiati S; Marsigit J
    Acta Med Indones; 2021 Jan; 53(1):1-4. PubMed ID: 33818400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delayed large local reactions to Moderna COVID-19 vaccine: A follow-up report after booster vaccination.
    Blumenthal KG; Ahola C; Anvari S; Samarakoon U; Freeman EE
    JAAD Int; 2022 Sep; 8():3-6. PubMed ID: 35434661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COVID-19 Vaccines: Current Status and Implication for Use in Indonesia.
    Ophinni Y; Hasibuan AS; Widhani A; Maria S; Koesnoe S; Yunihastuti E; Karjadi TH; Rengganis I; Djauzi S
    Acta Med Indones; 2020 Oct; 52(4):388-412. PubMed ID: 33377885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COVID arm as a common cutaneous manifestation after mRNA-1273 vaccination: a systematic review.
    Agustin M; Trifitriana M; Danarti R
    BMC Infect Dis; 2023 Jan; 23(1):7. PubMed ID: 36609222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FDA authorizes Moderna COVID-19 vaccine.
    Med Lett Drugs Ther; 2021 Jan; 63(1616):9-10. PubMed ID: 33512345
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.